Preview

Russian Journal of Gastroenterology, Hepatology, Coloproctology

Advanced search

Dysphoric spectrum of emotional disorders at irritable bowel syndrome

https://doi.org/10.22416/1382-4376-2017-27-1-12-22

Abstract

Aim of review. The role of emotional disorders of dysphoric range (irritability, strain, hostility etc.) in clinical presentation of the irritable bowel syndrome (IBS). Summary. Systematic literature search on severity of dysphoric disorders and their relation to somatic symptoms at IBS was carried out in the PubMed scientific database and Russian Science Citation Index (RSCI). Overall 42 articles were selected. The results of analysis has demonstrated that dysphoric emotional disorders are typical for IBS patients. These disorders are manifested as tendency to react by discontent and irritation in stressful situations. Somatic manifestations of IBS are associated to dysphoric experience indicating their potential pathogenic value. Imbalance between the scope of data on emotional disorders at IBS and the number of studies devoted to psychopharmacotherapy efficacy assessment at emotional disorders was revealed. Dysphoric disorders are not regarded as independent target for therapeutic actions. Conclusion. The chronic discontent and trend to react by anger to stressful situations are traits of IBS patients, and is the basis of the development and persistance of the somatic symtpoms. They have to be considered as an independent targets for medical care.

About the Authors

M. A. Morozova
Federal government-financed institution Mental Health Research Center of the Russian Academy of Medical Sciences
Russian Federation


G. Ye. Rupchev
Federal government-financed institution Mental Health Research Center of the Russian Academy of Medical Sciences
Russian Federation


A. A. Alekseyev
Federal government-financed institution Mental Health Research Center of the Russian Academy of Medical Sciences
Russian Federation


A. G. Beniashvili
Federal government-financed institution Mental Health Research Center of the Russian Academy of Medical Sciences
Russian Federation


M. V. Mayevskaya
The State Education Institution of Higher Professional Training The First Sechenov Moscow State Medical University
Russian Federation


Ye. A. Poluektova
The State Education Institution of Higher Professional Training The First Sechenov Moscow State Medical University
Russian Federation


O. Z. Okhlobystina
The State Education Institution of Higher Professional Training The First Sechenov Moscow State Medical University
Russian Federation


V. T. Ivashkin
The State Education Institution of Higher Professional Training The First Sechenov Moscow State Medical University
Russian Federation


References

1. Drossman D. A. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med 1999;107(5A):41-50.

2. Rey E., Talley N. J. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis 2009;41(11):772-80.

3. Психологический словарь / Под ред. А. В. Петровского, М. Г. Ярошевского. М.: Политиздат; 1990 [The psychological dictionary / ed:. A.V. Petrovsky, M.G. Yaroshevsky. M.: Politizdat; 1990].

4. Wu J. C. Psychological Co-morbidity in functional gastrointestinal disorders: Epidemiology, mechanisms and management. J Neurogastroenterol Motil 2012;18(1):13-8. doi: 10.5056/jnm.2012.18.1.13.

5. Sararoudi R. B., Afshar H., Adibi P., Daghaghzadeh H., Fallah J., Abotalebian F. Type D personality and quality of life in patients with irritable bowel syndrome. J Res Med Sci 2011;16(8):985-92. doi: 10.3748/wjg.v22. i28.6402.

6. Полуэктова Е. А., Курбатова А. А., Рупчев Г. Е., Шептулин А. А., Ивашкин В. Т. Роль эмоциональных расстройств, личностных особенностей и нарушений интрацептивных ощущений в формировании соматических симптомов у больных синдромом раздраженного кишечника. Рос журн гастроэнтерол гепатол колопроктол 2013;23(1):20-8.

7. Mayer E. A., Craske M., Naliboff B. D. Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry 2001;62 (Suppl. 8):28-36.

8. Bennett E. J., Tennant C. C., Piesse C., Badcock C-A., Kellow J. E. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998;43:256-61.

9. Hausteiner-Wiehle C., Henningsen P. Irritable bowel syndrome: relations with functional, mental, and somatoform disorders. World J Gastroenterol 2014;20(20):6024-30.

10. Canavan J. B., Bennett K., Feely J., O’Moráin C.A., O’Connor H. J. Significant psychological morbidity occurs in irritable bowel syndrome: a case-control study using a pharmacy reimbursement database. Aliment Pharmacol Ther 2009;29(4):440-9.

11. Shah E., Rezaie A., Riddle M., Pimentel M. Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? Ann Gastroenterol 2014;27(3):22430.

12. Muscatello M. R., Bruno A., Scimeca G., Pandolfo G., Zoccali R. A. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol 2014;20(24):7570-86. doi: 10.3748/wjg. v20.i24.7570.

13. Stănculete M. F., Pojoga C., Dumitraşcu D. L. Experience of anger in patients with irritable bowel syndrome in Romania. Clujul Medical 2014;87(2):98-101. doi:10.15386/cjmed-290.

14. Muscatello M. R., Bruno A., Pandolfo G., Mic ò.U., Stilo S., Scaffidi M., Consolo P., Tortora A., Pallio S., Giacobbe G., Familiari L., Zoccali R. Depression, anxiety and anger in subtypes of irritable bowel syndrome patients. J Clin Psychol Med Settings 2010;17(1):64-70.

15. Heymen S., Maixner W., Whitehead W. E., Klatzkin R. R., Mechlin B., Light K. C. Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls. Clin J Pain 2010;26(2):104-9. doi: 10.1097/Fizioter Lech Fiz Kult 2008;(5):6-8].

16. Beesley H., Rhodes J., Salmon P. Anger and childhood sexual abuse are independently associated with irritable bowel syndrome. Br J Health Psychol 2010;15(Pt 2):38999. doi: 10.1348/135910709X466496.

17. Altman G., Cain K.C., Motzer S., Jarrett M., Burr R., Heitkemper M. Increased symptoms in female IBS patients with dysmenorrhea and PMS. Gastroenterol Nurs 2006;29(1):4-11.

18. Zoccali R., Muscatello M.R., Bruno A., Barillà G., Campolo D., Meduri M., Familiari L., Bonica M., Consolo P., Scaffidi M. Anger and ego-defence mechanisms in non-psychiatric patients with irritable bowel syndrome. Dig Liver Dis 2006;38(3):195-200.

19. Huerta I., Bonder A., López L., Ocampo M.A., Schmulson M. Differences in the stress symptoms rating scale in Spanish between patients with irritable bowel syndrome (IBS) and healthy controls. Rev Gastroenterol Mex 2002;67(3):161-5.

20. Dickhaus B., Mayer E.A., Firooz N., Stains J., Conde F., Olivas T.I., Fass R., Chang L., Mayer M., Naliboff B.D. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol 2003;98(1):135-43.

21. Houghton L.A., Calvert E.L., Jackson N.A., Cooper P., Whorwell P.J. Visceral sensation and emotion: a study using hypnosis. Gut 2002;51(5):701-4.

22. Welgan P., Meshkinpour H., Ma L. Role of anger in antral motor activity in irritable bowel syndrome. Dig Dis Sci 2000;45(2):248-51.

23. Evans P.R., Bennett E.J., Bak Y.T., Tennant C.C., Kellow J.E. Jejunal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features. Gastroenterology 1996;110(2):393-404.

24. Whorwell P.J., Houghton L.A., Taylor E.E., Maxton D.G. Physiological effects of emotion: assessment via hypnosis. Lancet 1992;340(8811):69-72.

25. Welgan P., Meshkinpour H., Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology 1988;94(5 Pt 1):1150-6.

26. Arapakis G., Lyketsos C.G., Gerolymatos K., Richardson S.C., Lyketsos G.C. Low dominance and high intropunitiveness in ulcerative colitis and irritable bowel syndrome. Psychother Psychosom 1986;46(4):171-6.

27. Головин С.Ю. Словарь практического психолога. М.: Харвест; 1998 [Golovin S.Yu. Dictionary of the practical psychologist. M.: Harvest; 1998].

28. Bergeron C.M., Monto G.L. Personality patterns seen in irritable bowel syndrome patients. Am J Gastroenterol 1985;80(6):448-51.

29. Casiday R.E., Hungin A.P., Cornford C.S., de Wit N.J., Blell M.T. Patients’ explanatory models for irritable bowel syndrome: symptoms and treatment more important than explaining aetiology. Fam Pract 2009;26(1):40-7. doi: 10.1093/fampra/cmn087.

30. Марилов В.В. Психологический аспект психосоматической патологии толстой кишки. Журн неврологии и психиатрии им. С.С. Корсакова 2001;101(4):40-3.

31. Gulewitsch M.D., Enck P., Schwille-Kiuntke J., Weimer K., Schlarb A.A. Mental strain and chronic stress among university students with symptoms of irritable bowel syndrome. Gastroenterol Res Pract 2013;2013:206574. doi: 10.1155/2013/206574.

32. Айвазян Т.А., Зайцев В.П., Пахомова И.В., Гусакова Е.В. Предикторы эффективности методов психокоррекции у пациентов с синдромом раздраженного кишечника и запорами. Вопр Курортол Физиотер Леч Физ Культ 2008;(5):6-8.

33. Dotevall G., Svedlund J., Sjödin I. Symptoms in irritable bowel syndrome. Scand J Gastroenterol 1982;79 (Suppl.):16-9.

34. Вашадзе Ш.В. Психологические аспекты психосоматической патологии толстой кишки. Georgian Med News 2009;171:37-40 .

35. Singh P., Staller K., Barshop K., Dai E., Newman J., Yoon S., Castel S., Kuo B. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World J Gastroenterol 2015;21(26):8103-9. doi: 10.3748/wjg.v21. i26.8103.

36. Solem C.T., Patel H., Mehta S., Mody R., Macahilig C., Gao X. Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone inirritable bowel syndrome constipation subtype. Curr Med Res Opin 2016;32(5):899-905. doi:10.1185/0300799 5.2016.1150262.

37. Wu X.W., Hou Y., Ji H.Z., Liang M.M., Xu L.E., Wang F.Y. Treating irritable bowel syndrome by wuling capsule combined pinaverium bromide: a clinical research. Zhongguo Zhong Xi Yi Jie He Za Zhi 2015;35(4):415-8.

38. Jang A.L., Hwang S.K., Kim D.U. The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: a randomized trial. Eur J Gastroenterol Hepatol 2014;26(8):918-26. doi: 10.1097/ MEG.0000000000000140.

39. Sun J.H., Wu X.L., Xia C., Xu L.Z., Pei L.X., Li H., Han G.Y. Clinical evaluation of Soothing Gan and invigorating Pi acupuncture treatment on diarrheapredominant irritable bowel syndrome. Chin J Integr Med 2011;17(10):780-5. doi: 10.1007/s11655-011-0875-z.

40. Choi C.H., Jo S.Y., Park H.J., Chang S.K., Byeon J.S., Myung S.J. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J Clin Gastroenterol 2011;45(8):679-83. doi: 10.1097/ MCG.0b013e318204593e.

41. Jones M.P., Bratten J., Keefer L. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet. Am J Gastroenterol 2007;102(10):2232-7.

42. Wang W.A., Qian J.M., Pan G.Z. Treatment of refractory irritable bowel syndrome with subclinical dosage of antidepressants. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2003;25(1):74-8.

43. Wang W., Pan G., Qian J. Cognitive therapy for patients with refractory irritable bowel syndrome. Zhonghua Nei Ke Za Zhi 2002;41(3):156-9.

44. Dumitraşcu D.L., Acalovschi M., Pascu O. Hostility in patients with chronic constipation. Rom J Intern Med 1998;36(3-4):239-43.

45. Nam S.Y., Ryu K.H., Park B.J. Irritable bowel syndrome is associated with gastroesophageal reflux symptom but not erosive esophagitis. J Neurogastroenterol Motil 2013;19(4):521-31. doi: 10.5056/jnm.2013.19.4.521.

46. Thakur E.R., Gurtman M.B., Keefer L., Brenner D.M., Lackner J.M. Gender differences in irritable bowel syndrome: the interpersonal connection. Neurogastroenterol Motil 2015;27(10):1478-86. doi: 10.1111/nmo.12647.

47. Lembo T., Fullerton S., Diehl D., Raeen H., Munakata J., Naliboff B., Mayer E.A. Symptom duration in patients with irritable bowel syndrome. Am J Gastroenterol 1996;91(5):898-905.

48. Whitehead W.E., Engel B.T., Schuster M.M. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipationpredominant patients. Dig Dis Sci 1980;25(6):404-13.

49. Dumitraşcu D.L., Grănescu S. Colonic transit investigated by radiopaque markers in females with irritable bowel syndrome: no correlation with symptoms and chronic stress. Rom J Intern Med 1996;34(3-4):225-31.

50. Муравьева Н.Н., Ляляева Т.В., Успенский Ю.П., Эглит А.Э. Влияние синдрома раздраженного кишечника на психический статус и качество жизни детей. Профилакт клин мед 2005; 3:77-80.

51. Белов В.Г., Дашдемиров А.Г., Белова Н.В., Парфенов Ю.А. Личностные предикторы психосоматических расстройств при синдроме раздраженного кишечника у военнослужащих. Ученые записки университета им. П.Ф. Лесгафта 2010;8:13-8.

52. Тихонова Т.А. Объективные и субъективные подходы в тактике ведения пациентов с заболеваниями кишечника. Бюлл мед интернет-конференций 2014;4(5):536 .

53. Козлова И.В., Мялина Ю.Н., Лекарева Л.И., Бадиева О.Е., Тихонова Т.А. Психологические особенности пациентов с функциональными и воспалительными заболеваниями кишечника. Саратовский науч-мед журн 2014;10(1):80-5

54. Есаулов В.И. О некоторых эмоционально-личностных характеристиках пациентов с синдромом раздраженного кишечника. Eur Res 2015;5:76-8.

55. Наумова Е.Л., Куприянова И.Е., Белобородова Э.И. Адаптивные копинг-стратегии у пациентов с синдромом раздраженного кишечника. Сибирский вестн психиатр наркол 2014;2:62-4

56. World Gastroenterology Organisation. Global guidelines irritable bowel syndrome: A global perspective. Update September 2015. Available From: URL: http://www. worldgastroenterology.org/UserFiles/file/guidelines/ irritable-bowel-syndrome-english-2015.pdf

57. Sinagra E., Romano C., Cottone M. Psychopharmacological treatment and psychological interventions in irritable bowel syndrome. Gastroenterol Res Pract 2012;2012:486067. doi: 10.1155/2012/486067.

58. Xie C., Tang Y., Wang Y., Yu T., Wang Y., Jiang L., Lin L. Efficacy and safety of antidepressants for the treatment of irritable bowel syndrome: A meta-analysis. PLoS One. 2015;10(8):e0127815. doi: 10.1371/journal. pone.0127815.

59. Ford A.C., Quigley E.M., Lacy B.E., Lembo A., Saito Y.A., Schiller L.R., Soffer E.E., Spiegel B.M., Moayyedi P. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(9):1350-65. doi: 10.1038/ ajg.2014.148.


Review

For citations:


Morozova M.A., Rupchev G.Ye., Alekseyev A.A., Beniashvili A.G., Mayevskaya M.V., Poluektova Ye.A., Okhlobystina O.Z., Ivashkin V.T. Dysphoric spectrum of emotional disorders at irritable bowel syndrome. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(1):12-22. (In Russ.) https://doi.org/10.22416/1382-4376-2017-27-1-12-22

Views: 1187


ISSN 1382-4376 (Print)
ISSN 2658-6673 (Online)